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Introduction
Autosomal Recessive Osteopetrosis (ARO) is a severe
bone disease characterized by increased bone density due
to impairment in osteoclast bone resorptive function
(osteoclast-rich forms) or differentiation (osteoclast-poor
forms). The latter form carries mutations in Tnfsf11
gene, which codifies for the receptor activator of NF-B
ligand (RANKL), an essential cytokine expressed in stro-
mal cells. It contributes (with M-CSF) to the differentia-
tion and activation of specialized osteoclasts from
monocyte precursors in bone marrow niche. These
patients, differently from other forms, do not benefit
from HSC transplantation, demonstrating a pathogenetic
role of stromal cells in unbalanced bone remodeling.
Objectives
Aim of the project is to characterize the stromal compart-
ment in a murine model of osteopetrosis, RANKL defi-
cient. In order to verify whether a defect in RANKL
protein might cause an impairment in this compartment
we generated bone marrow mesenchymal stromal cells
(BM-MSC) from knockout mice. We investigated whether
nonfunctional RANKL alters physiological features such as
morphology and phenotype of MSCs. In order to evaluate
if a defect in RANKL affects the physiological functions of
MSCs, the clonogenic, proliferative and differentiation
potential towards the osteogenic and adipogenic lineages
was assayed.
Methods
MSCs were isolated from bones of wt and ko mice and
were cultured in vitro with selective medium. Cell surface
markers and proliferation were analyzed through flow
citometry and CFSE labeling. Differentiation in vitro
was induced with a specific medium for osteoblastic or
adipogenic lineage. Alizarin Red and Oil Red staining was
performed to confirm the differentiation respectively for
OBs and adipocytes.
Results
7 BM MSC lines from wt and 6 MSCs from ko mice have
been generated. We analyzed the immune-phenotype
using the following markers: CD45, CD34, CD9, SCA1,
CD62L, CD117, CD44 and we observed a comparable
phenotype despite a reduction in CD9 expression in
Rankl-/- MSCs.We tested the clonogenic potential of KO
MSCs and we observed a reduced capacity to form CFU,
whereas the proliferation of ko MSCs was not different
from the one of wt MSCs. Finally we evaluated the differ-
entiation potential in vitro of Rankl -/- MSCs and we
found that they are able to differentiate into osteoblasts
(OBs) and adipocytes, but the osteoblastogenesis is
reduced with respect to wt cells, even if not in significant
manner. Indeed we analyzed the expression of osteoblas-
tic markers (RUNX2, OSP, ALP, COL1) and we observed
that during the differentiation ko MSCs express OSP and
ALP at lower level than wt MSCs.
Conclusion
These results show that nonfunctional RANKL affects
the expression in CD9, influences the intrinsic clonogenic
potential of MSCs and the capacity to differentiate to OB
suggesting a possible role of RANKL cytokine in stromal
cell physiology and a consequent pathogenic role of bone
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